 CAMBRIDGE, Mass.--BUSINESS WIRE--Infinity Pharmaceuticals, Inc. NASDAQ: INFI will hold a conference call on Wednesday, December 9, 2020 at 10:00 a.m. ET to discuss clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer TNBC which will be presented during the San Antonio Breast Cancer Symposium SABCS being held virtually, December 8-11, 2020. Conference Call Information A live webcast of the conference call can be accessed in the InvestorsMedia secti 